Work

High-Dose (HD) Imatinib Provides Better Responses in Patients with Untreated Early Chronic Phase (CP) CML.

Year: 2006

Type: article

Source: Blood

DOI: 10.1182/blood.v108.11.2143.2143

Authors: tsuko Aoki, Hagop Kantarjian, Susan O’Brien, Moshe Talpaz, Francis Giles, Srdan Verstovsek, William Wierda, August Salavado, Lauri Letvak, Guillermo Garcia-Manero, Dan Jones, Rajyalakshmi Luthra, Jianqin Shan, Jorge Cortes

Institutions: The University of Texas MD Anderson Cancer Center, University of Michigan

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979599684

FWCI: 1.627

Cites:

Cited by: 10

Related to: 10